Skip to main content

Your search for “vaccines” returned 301 results

‘Comet’ Supercomputer Calculations Boost Our Understanding of Immune System

October 7, 2020

A team from the San Diego Supercomputer Center at UC San Diego contributed to a study led by the Vanderbilt Vaccine Center on T cell receptors, which play a vital role in alerting the adaptive immune system to mount an attack on invading foreign pathogens, including Coronavirus SARS-CoV-2.

Strauss Family Gives UC San Diego $1 Million to Help Develop a Cancer Vaccine

October 17, 2017

…over the next year designed to develop personalized cancer vaccines—a breakthrough treatment that could help patients like their daughter fight the disease using their own immune system.

For Transplant Patients, COVID-19 Vaccination Presents a Different Uncertainty

July 1, 2021

Researchers at UC San Diego Health have launched a pair of clinical trials to study the immune response of COVID-19 vaccinated transplant recipients of bone marrow and solid organs, such as the heart, lung, liver and kidney.

The Impact of COVID-19 on San Diego’s Refugee Community

April 22, 2021

…to receive their COVID-19 vaccine at the UC San Diego Health mobile vaccine clinic in City Heights. The Impact of COVID-19 on San Diego’s Refugee Community When COVID-19 officially became a pandemic in March 2020, the world and life as we knew it changed. Grocery store shelves emptied. Shelter-at-home orders…

Groundbreaking Research Paves the Way for Acne Vaccine

December 20, 2023

In a groundbreaking development in the field of anti-acne therapies, a team of researchers has created an acne vaccine that, when used in a mouse acne model, neutralizes a specific variant of an enzyme produced by an acne-associated bacteria while leaving the healthy bacterial enzyme intact.

Study: No Serious COVID-19 Vaccine Side Effects in Breastfeeding Moms, Infants

September 8, 2021

Researchers found that breastfeeding mothers who received either the Pfizer-BioNTech or Moderna vaccination reported the same local or systemic symptoms as what has been previously reported in non-breastfeeding women, with no serious side effects in the breastfed infants.

Q&A: Realism on Achieving Herd Immunity with Dr. Chip Schooley

August 4, 2021

“When will we get ‘back to normal?’” is a question looming on many Americans’ minds. The answer largely depends on the country’s ability to substantially ramp up immunity to SARS CoV-2.

Q&A: When Will a COVID-19 Vaccine Be Ready?

October 15, 2020

…When Will a COVID-19 Vaccine Be Ready? UC San Diego’s fall plan continues to evolve, informed by the university’s Return to Learn program. We invited students, faculty and staff to submit their questions, including how UC San Diego is involved in COVID-19 vaccine development, when a vaccine may be approved,…

Nanoparticle Vaccine Could Curb Cancer Metastasis to Lungs by Targeting a Protein

October 18, 2023

UC San Diego engineers have developed an experimental vaccine that could prevent the spread of metastatic cancers to the lungs. Its success lies in targeting a protein known to play a central role in cancer growth and spread, rather than targeting the primary tumor itself.

Nanosponge Vaccine Fights MRSA Toxins

December 2, 2013

…a safe and effective vaccine against this toxin. This “nanosponge vaccine” enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA—both within the bloodstream and on the skin. Nanoengineers from the University of California, San Diego described the safety and efficacy of this…

Category navigation with Social links